CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL | Zendy

Vincenzo Accurso | Zendy; Marco Santoro | Zendy; Salvatrice Mancuso | Zendy; Angelo Davide Contrino | Zendy; Paolo Casimio | Zendy; Mariano Sardo | Zendy; Simona Raso | Zendy; F. Di Piazza | Zendy; Alessandro Perez | Zendy; Marco Bono | Zendy; Antonio Russo | Zendy; Sergio Siragusa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL

Author(s) -

Vincenzo Accurso,

Marco Santoro,

Salvatrice Mancuso,

Angelo Davide Contrino,

Paolo Casimio,

Mariano Sardo,

Simona Raso,

F. Di Piazza,

Alessandro Perez,

Marco Bono,

Antonio Russo,

Sergio Siragusa

Publication year - 2020

Publication title -

mediterranean journal of hematology and infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 31

ISSN - 2035-3006

DOI - 10.4084/mjhid.2020.008

Subject(s) - essential thrombocythemia , medicine , polycythemia vera , dyslipidemia , diabetes mellitus , thrombosis , platelet , myelofibrosis , gastroenterology , obesity , cardiology , endocrinology , bone marrow

Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant role can be played by cardiovascular risk factors (CV.R) such as cigarette smoking habits, hypertension, diabetes, obesity and dyslipidemia. In this study, we evaluated the impact that CV.R plays on thrombotic risk and survival in patients with PV and ET.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research